Guardian Capital LP Astrazeneca PLC Transaction History

Guardian Capital LP

  • $2.6 Billion
  • Q1 2024

A detailed history of Guardian Capital LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Guardian Capital LP holds 52,274 shares of AZN stock, worth $4.04 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
52,274
Previous 47,289 10.54%
Holding current value
$4.04 Million
Previous $3.18 Million 11.21%
% of portfolio
0.14%
Previous 0.13%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$61.03 - $69.57 $304,234 - $346,806
4,985 Added 10.54%
52,274 $3.54 Million
Q4 2023

Feb 08, 2024
SELL
$61.89 - $69.28 $298,928 - $334,622
-4,830 Reduced 9.27%
47,289 $3.18 Million
Q3 2023

Nov 13, 2023
SELL
$64.85 - $71.7 $112,514 - $124,399
-1,735 Reduced 3.22%
52,119 $3.53 Million
Q2 2023

Aug 14, 2023
SELL
$69.91 - $75.81 $87,806 - $95,217
-1,256 Reduced 2.28%
53,854 $3.85 Million
Q1 2023

May 15, 2023
SELL
$63.15 - $71.6 $159,895 - $181,291
-2,532 Reduced 4.39%
55,110 $3.83 Million
Q4 2022

Feb 14, 2023
SELL
$54.21 - $70.44 $71,990 - $93,544
-1,328 Reduced 2.25%
57,642 $3.91 Million
Q3 2022

Nov 14, 2022
BUY
$53.02 - $135.75 $177,829 - $455,305
3,354 Added 6.03%
58,970 $3.23 Million
Q2 2022

Aug 12, 2022
BUY
$59.26 - $71.14 $1.15 Million - $1.39 Million
19,474 Added 53.88%
55,616 $3.68 Million
Q1 2022

May 16, 2022
BUY
$55.72 - $67.12 $16,270 - $19,599
292 Added 0.81%
36,142 $2.4 Million
Q4 2021

Feb 10, 2022
SELL
$54.02 - $63.83 $191,716 - $226,532
-3,549 Reduced 9.01%
35,850 $2.09 Million
Q3 2021

Nov 15, 2021
SELL
$55.56 - $60.79 $45,725 - $50,030
-823 Reduced 2.05%
39,399 $2.37 Million
Q2 2021

Aug 17, 2021
BUY
$48.42 - $60.18 $16,414 - $20,401
339 Added 0.85%
40,222 $2.41 Million
Q1 2021

May 17, 2021
SELL
$47.16 - $54.44 $790,024 - $911,978
-16,752 Reduced 29.58%
39,883 $1.98 Million
Q4 2020

Feb 12, 2021
SELL
$48.52 - $58.02 $3,396 - $4,061
-70 Reduced 0.12%
56,635 $2.83 Million
Q3 2020

Nov 16, 2020
BUY
$53.07 - $61.1 $6,952 - $8,004
131 Added 0.23%
56,705 $3.11 Million
Q2 2020

Aug 13, 2020
SELL
$43.1 - $55.31 $14,654 - $18,805
-340 Reduced 0.6%
56,574 $2.99 Million
Q1 2020

May 15, 2020
BUY
$37.79 - $51.33 $836,632 - $1.14 Million
22,139 Added 63.66%
56,914 $2.54 Million
Q4 2019

Feb 13, 2020
SELL
$42.46 - $50.46 $2.29 Million - $2.73 Million
-54,021 Reduced 60.84%
34,775 $1.73 Million
Q3 2019

Nov 14, 2019
BUY
$40.12 - $45.47 $723,243 - $819,687
18,027 Added 25.47%
88,796 $3.96 Million
Q2 2019

Aug 14, 2019
BUY
$37.28 - $41.68 $146,808 - $164,135
3,938 Added 5.89%
70,769 $2.92 Million
Q1 2019

May 15, 2019
SELL
$35.49 - $43.02 $2.17 Million - $2.63 Million
-61,153 Reduced 47.78%
66,831 $2.7 Million
Q4 2018

Feb 13, 2019
SELL
$36.86 - $41.49 $496,909 - $559,326
-13,481 Reduced 9.53%
127,984 $4.86 Million
Q3 2018

Nov 13, 2018
SELL
$34.76 - $39.72 $75,324 - $86,073
-2,167 Reduced 1.51%
141,465 $5.6 Million
Q2 2018

Aug 14, 2018
SELL
$34.55 - $37.05 $451,084 - $483,724
-13,056 Reduced 8.33%
143,632 $5.04 Million
Q1 2018

May 15, 2018
SELL
$32.97 - $36.63 $84,666 - $94,065
-2,568 Reduced 1.61%
156,688 $5.48 Million
Q4 2017

Feb 14, 2018
SELL
$32.09 - $34.78 $113,020 - $122,495
-3,522 Reduced 2.16%
159,256 $5.53 Million
Q3 2017

Nov 15, 2017
SELL
$28.96 - $34.0 $92,672 - $108,800
-3,200 Reduced 1.93%
162,778 $5.52 Million
Q2 2017

Aug 14, 2017
BUY
N/A
165,978
165,978 $5.66 Million

Others Institutions Holding AZN

# of Institutions
1,248
Shares Held
477M
Call Options Held
5.99M
Put Options Held
5.24M
View Full List

About ASTRAZENECA PLC

AZN Quotes by TradingView
  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Guardian Capital LP Portfolio

Follow Guardian Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email